Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 69

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 69
---
iamen City,

Fujian Province, China, 361013

+86-592-5586999</div>

You should rely only on the information that we
incorporate by reference or provide in this prospectus supplement. We have not authorized anyone to provide you with different information.
We are not making any offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume
that the information contained or incorporated in this prospectus supplement by reference is accurate as of any date other than the date
of the document containing the information.

<div align='center'>S-32

WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>

As permitted by SEC rules, this prospectus supplement
omits certain information and exhibits that are included in the registration statement of which this prospectus supplement forms a part.
Since this prospectus supplement may not contain all of the information that you may find important, you should review the full text of
these documents. If we have filed a contract, agreement, or other document as an exhibit to the registration statement of which this prospectus
supplements forms a part, you should read the exhibit for a more complete understanding of the document or matter involved. Each statement
in this prospectus supplement, including statements incorporated by reference as discussed above, regarding a contract, agreement, or
other document is qualified in its entirety by reference to the actual document.

We are subject to periodic reporting and other
informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we are required to file
reports, including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC can be inspected
over the Internet at the SEC’s website at www.sec.gov and copied at the public reference facilities maintained by the SEC at 100
F Street, N.E., Washington, D.C. 20549. You can request copies of these documents, upon payment of a duplicating fee, by writing to the
SEC.

As a foreign private issuer, we are exempt under
the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our executive
officers, directors, and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in
Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic or current reports
and financial statements with the SEC as frequently or as promptly as